Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-08-002345
Filing Date
2008-02-29
Accepted
2008-02-29 14:55:04
Documents
14
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K y50446e10vk.htm 10-K 1045780
2 EX-10.28: AMENDED AND RESTATED EMPLOYMENT AGREEMENT y50446exv10w28.htm EX-10.28 8045
3 EX-12.1: COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES y50446exv12w1.htm EX-12.1 19436
4 EX-21.1: SUBSIDIARIES y50446exv21w1.htm EX-21.1 2096
5 EX-23.0: CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM y50446exv23w0.htm EX-23.0 2291
6 EX-31.1: CERTIFICATION y50446exv31w1.htm EX-31.1 8966
7 EX-31.2: CERTIFICATION y50446exv31w2.htm EX-31.2 8879
8 EX-32.1: CERTIFICATION y50446exv32w1.htm EX-32.1 3854
9 EX-32.2: CERTIFICATION y50446exv32w2.htm EX-32.2 3546
10 EX-99.1: CONSENT OF INDEPENDENT VALUATION FIRM y50446exv99w1.htm EX-99.1 3833
11 GRAPHIC y50446y5044601.gif GRAPHIC 8983
12 GRAPHIC y50446y5044600.gif GRAPHIC 4172
13 GRAPHIC y50446y5044602.gif GRAPHIC 2419
14 GRAPHIC y50446y5044603.gif GRAPHIC 4735
  Complete submission text file 0000950123-08-002345.txt   1137054
Mailing Address 685 ROUTE 202/206 ATT: GENERAL COUNSEL BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 BRIDGEWATER NJ 08807 908 541 8671
ENZON PHARMACEUTICALS INC (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-12957 | Film No.: 08654898
SIC: 2836 Biological Products, (No Diagnostic Substances)